March 06, 2015 3:13 AM ET


Company Overview of PhaseBio Pharmaceuticals, Inc.

Executive Profile

Christopher P. Prior Ph.D.

Former Chief Executive Officer and Director, PhaseBio Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 3 different industries.



Dr. Christopher P. Prior, also known as Chris, Ph.D. served as Chief Executive Officer of PhaseBio Pharmaceuticals, Inc. since April 2008. Dr. Prior served as the President and Chief Scientific Officer of BioRexis Pharmaceuticals Corporation. He was Founder of Principia Pharmaceuticals Corporation and served as its President. Prior to founding BioRexis, Dr. Prior founded Principia Pharmaceuticals Corp. and served as its president. He was a Senior Executive at Human Genome ...

Corporate Headquarters

One Great Valley Parkway
Malvern, Pennsylvania 19355

United States

Phone: 610-981-6500
Fax: 610-981-6520

Board Members Memberships

Former President and Chief Scientific Officer
Former Chief Executive Officer and Director


Columbia University
Post-Doctoral Training
Rockefeller University
University Of London

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PhaseBio Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at